What is Citius Oncology, Inc.'s repayments of notes payable?

Citius Oncology, Inc. (CTOR) reported repayments of notes payable of $20M in Q3 2025.

What does repayments of notes payable mean?

The cash outflow associated with the reduction or settlement of principal amounts on debt obligations. This metric is a key indicator of the company's liquidity management and its ability to deleverage its balance sheet over time.

Citius Oncology, Inc. CTOR Repayments of Notes Payable

Repayments of Notes Payable at other companies

American Assets TrustAAT

$0-100%

Century CommunitiesCCS

$9M+15.6%

RGC ResourcesRGCO

$711.5K-84.3%

CTO

Citius Oncology, Inc.CTOR

$20M-60.0%

PopularBPOP

$25M-60.6%

SVC

Stellar V Capital Corp. Class A Ordinary SharesSVCC

$242.7K—

Other financials

Income statement

See full

Revenue$1.7M—

Gross profit$1.3M—

Operating income-$28.6M-283%

Net income-$26.6M-244%

EPS (diluted)-$0.27-145%

Balance sheet

See full

Cash & equivalents$2.6M+2,350,466%

Total equity$35.3M-1.0%

Total assets$100.7M+10.1%

Cash flow

See full

Operating cash flow-$3.8M-179%

Valuation

See full

Market cap$60.45M-74.7%

Returns & leverage

See full

Return on equity-119.9%+46.7pp

Current ratio0.5×+0.1×

Where this comes from

Reported directly by Citius Oncology, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RepaymentsOfNotesPayable.

The official record: Citius Oncology, Inc.’s 10-K, filed December 23, 2025, on SEC EDGAR. View the filing →

Ask your AI about Citius Oncology, Inc.'s repayments of notes payable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Citius Oncology, Inc.'s repayments of notes payable?: Citius Oncology, Inc. (CTOR) reported repayments of notes payable of $20M in Q3 2025.
What does repayments of notes payable mean?: The cash outflow associated with the reduction or settlement of principal amounts on debt obligations. This metric is a key indicator of the company's liquidity management and its ability to deleverage its balance sheet over time.